Dermatology · New Hyde Park, NY
NPI
1245211127
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1991 Marcus Ave, Suite 300
New Hyde Park, NY, 11042
Phone (516) 321-8543
Groups this clinician bills Medicare through
Medicare paid, 2024
$132K
1,534 services
Medicare patients, 2024
252
Average age 72
Drug cost, 2024
$1.3M
680 prescriptions
Company payments, 2025
$204K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amit Garg was code 17003 (destruction skin lesion), 185 times for 30 patients. In total Amit Garg billed 1,534 services in 26 codes, and Medicare paid $132K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-12-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 185 | 30 | $5.72 | $1,059 |
| 99214 Office E&M - Established | Office | 155 | 84 | $108.67 | $17K |
| 99213 Office E&M - Established | Office | 113 | 100 | $71.34 | $8,061 |
| 99203 Office E&M - New | Office | 56 | 56 | $90.93 | $5,092 |
| 17000 Destruction Skin Lesion | Office | 51 | 40 | $52.30 | $2,667 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 38 | 28 | $14.53 | $552 |
| 11102 Skin Biopsy | Office | 26 | 26 | $77.52 | $2,015 |
| 99204 Office E&M - New | Office | 22 | 22 | $128.10 | $2,818 |
| 17110 Destruction Skin Lesion | Office | 18 | 16 | $96.22 | $1,732 |
By year: 2022 $66K for 890 services; 2023 $92K for 1,137 services; 2024 $132K for 1,534 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amit Garg prescribed most often to Medicare patients was Triamcinolone Acetonide, with 102 prescriptions and refills. In total Amit Garg wrote 680 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 102 | 113 | 63 | $1,587 |
| Ketoconazole Generic | 48 | 53 | 22 | $1,315 |
| Methotrexate Methotrexate Sodium | 36 | 39 | Under 11 | $484 |
| Hydrocortisone Generic | 31 | 31 | 15 | $150 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 31 | 32 | Under 11 | $293K |
| Clobetasol Propionate Generic | 31 | 32 | 20 | $1,552 |
| Betamethasone Dipropionate Generic | 28 | 28 | 12 | $951 |
| Mycophenolate Mofetil Generic | 24 | 35 | Under 11 | $1,390 |
| Tremfya Guselkumab | 21 | 36 | Under 11 | $265K |
| Gabapentin Generic | 19 | 24 | Under 11 | $222 |
| Fluorouracil Generic | 17 | 17 | 11 | $877 |
| Clindamycin Phosphate Generic | 16 | 18 | Under 11 | $421 |
| Mometasone Furoate Generic | 16 | 16 | Under 11 | $516 |
| Prednisone Generic | 15 | 15 | 11 | $94.5 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 15 | 15 | Under 11 | $976 |
Brand drugs: 152 claims; generic drugs: 528 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amit Garg $204K ($176K in general payments such as food, travel and fees and $29K for research) from 15 companies. The largest payer was Insmed, Inc. with $52K.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 10 | $52K |
| Abbvie Inc. ABBV | 33 | $36K |
| Novartis Pharmaceuticals Corporation NVS | 19 | $30K |
| UCB, Inc. UCB.BR | 36 | $25K |
| Incyte Corporation INCY | 22 | $14K |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 10 | $14K |
| Sanofi US Services Inc. SNY | 3 | $11K |
| Ucb Sa UCB.BR | 3 | $5,850 |
| Almirall LLC | 4 | $5,248 |
| Novartis Pharma AG NVS | 2 | $4,400 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.